American Society of Hirudotherapy

Ischial Bursitis (Investigational Adjunct)

Investigational adjunct for refractory ischial (ischiogluteal) bursitis; activity modification, hamstring loading, and selective injection remain primary.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 10, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for ischial bursitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational; no clinical study was identified.
What evidence exists?
Tier C (investigational). No clinical study of leech therapy for ischial bursitis was identified in PubMed or Europe PMC, so its benefit is unknown. Ischial (ischiogluteal) bursitis presents as posterior buttock pain worsened by prolonged sitting and often overlaps with proximal hamstring tendinopathy. Evidence-based management is activity and seating modification, progressive hamstring loading, NSAIDs, and ultrasound-guided corticosteroid injection in refractory cases. The sciatic nerve runs close to the ischial tuberosity, so placement requires careful anatomic knowledge.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the posterior buttock for 5 to 14 days
  • Local skin infection or Aeromonas infection
  • Allergic reaction to leech saliva
  • Sciatic nerve irritation if a leech is placed medial to the safe zone (the nerve passes deep to the piriformis here)
  • Worsening of any underlying hamstring tendinopathy
  • Delay of structured hamstring loading and corticosteroid injection, both of which are evidence-supported
  • Missed hamstring avulsion or sciatic radiculopathy if workup is incomplete
Who should not consider this
  • Patients with hamstring avulsion or partial tear (orthopedic referral)
  • Patients with sciatica or lumbar radicular pain (workup first)
  • Patients within 4 weeks of local corticosteroid injection
  • Patients unable to tolerate prone positioning
  • Patients on anticoagulants or with anemia
  • Patients who have not completed at least 12 weeks of structured hamstring loading and seating modification
What to ask your clinician
  • Has imaging excluded hamstring avulsion, enthesopathy, or referred lumbar pathology?
  • Have I completed at least 12 weeks of progressive hamstring loading and seating modification?
  • Has ultrasound-guided corticosteroid injection been considered?
  • Where exactly will the leech be placed — confirm clearly lateral to the ischial tuberosity and away from the sciatic nerve course?
  • What is the practitioner's anatomical familiarity for this site?
  • What is the realistic expected benefit, given that no clinical study for this condition was identified?
When to seek urgent care
  • New or worsening sciatic-type pain radiating down the leg
  • New numbness, weakness, or foot drop
  • Bowel or bladder dysfunction (cauda equina concern)
  • Sudden severe posterior thigh pain with bruising (possible hamstring avulsion)
  • Spreading redness, warmth, pus, or red streaks at any bite site
  • Fever above 38.0 C / 100.4 F or chills

What this does NOT mean

  • It does not replace progressive hamstring loading, which is the strongest evidence intervention for the underlying tendinopathy.
  • It does not address hamstring avulsion, sciatica, or referred lumbar pain — these need separate workup.
  • It is not placed near the sciatic nerve, which lies medial and deep to typical lateral application sites.
  • No clinical evidence of benefit was identified; any perceived benefit may be largely time-and-attention-related rather than specific.

Clinical Profile

Category
Musculoskeletal
ICD-10
M70.70, M70.79
Safety tier
Medium

Evidence Summary

Ischial (ischiogluteal) bursitis presents as posterior buttock pain worsened by prolonged sitting, often overlapping with proximal hamstring tendinopathy. Evidence-based management is activity and seating modification, progressive hamstring loading, NSAIDs, and ultrasound-guided corticosteroid injection in refractory cases. Imaging should rule out enthesopathy and avulsion. No clinical study or case report of hirudotherapy for ischial bursitis or proximal hamstring tendinopathy was identified in PubMed, Europe PMC, ClinicalTrials.gov, Russian- or German-language sources or the Baskova and Isakhanyan 2004 monograph. Any rationale is extrapolated from leech studies in other musculoskeletal conditions (for example knee osteoarthritis and lateral epicondylitis), and the benefit for this condition is unknown. Sciatic nerve runs close to the ischial tuberosity, so placement requires careful anatomic knowledge.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Hamstring avulsion or partial tear (orthopedic referral)
  • Sciatica or radicular pain (workup first)
  • Recent corticosteroid injection at the site (within 4 weeks)
  • Inability to tolerate prone positioning

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.